Association between Q192R PON1 genetic polymorphism and major adverse cardiovascular events in patients treated with clopidogrel: an updated meta-analysis.

Mohitosh BiswasSumaiya Khatun KaliAshish SarkerChonlaphat Sukasem

Published in: Expert opinion on drug safety (2023)

The results suggest that the Q192R PON1 genetic polymorphism has no significant impact on the risk of MACEs or bleeding events in patients treated with clopidogrel.

Keyphrases

cardiovascular events
acute coronary syndrome
systematic review
coronary artery disease
percutaneous coronary intervention
antiplatelet therapy
genome wide
cardiovascular disease
copy number
atrial fibrillation
type diabetes
dna methylation
adverse drug
drug induced